Please Wait...

Cardiovascular Imaging

Cardiovascular Imaging Expertise

Advances in medical imaging offer clinicians and sponsors sensitive and quantitative measurements of cardiac structure and function. While these advances enable increasingly sensitive assessments of drug safety and efficacy, the success of your clinical trial depends on the selection and accurate measurement of cardiovascular endpoints.

Bioclinica's cardiovascular team has experience with all imaging modalities including the latest innovations in molecular imaging and echocardiographic strain, helping you design and support the evaluation of your drug or medical device.

Download Overview Sheet

Cardiac Safety

The association of many oncology drugs with cardiotoxic side effects necessitates independent cardiac safety studies for therapies in development. Bioclinica has extensive expertise in cardiac safety including ICH-E14 mandated Thorough QT services, blood pressure analysis and more. Many times cardiovascular imaging services are also included to assess the impact of cancer therapy agents on cardiac structure and function early in clinical development.

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support your next trial.


Bioclinica's Cardiovascular Therapeutic Strengths include:

  World leader in centralized imaging services, providing sponsors with comprehensive support for clinical trials across all major cardiovascular indications.

  Understand the complexities of imaging endpoints required for monitoring specific disease states.

  There are many cardiovascular imaging choices to consider and we will help sort through the technical requirements, acquisition challenges, costs and advise on the most appropriate endpoints for your clinical study.

    Bioclinica's Cardiovascular Services include:

      Latest developments in imaging endpoints

      Qualitative and quantitative image analysis for all imaging modalities

      Full 21 CFR Part 11 compliance

      Protocols to maintain contact with the FDA to implement regulatory guidance

      Bioclinica's Cardiovascular Modalities supported include:


      Cardiac MR

      Nuclear Imaging

      Cardiac CT



      Cardiovascular Imaging Indications:

      • Heart Failure
      • Cardiotoxicity (Safety)
      • Cardiomyopathy
      • Atherosclerosis
      • Hypertension
      • Fibrosis
      • Ischemia
      • LV Dysfunction
      • Rare Diseases
      • Vascular Thrombosis
      • Prosthetic valves
      • Medical devices

      Bioclinica’s application of SMART in Cardiovascular Imaging

      Bioclinica advances clinical trials via SMART — a robust suite of centralized medical imaging services designed to manage the complex imaging process from image receipt to analysis, to regulatory submission.

      Cardiovascular Imaging Endpoints

      Your trial depends on the selection and accurate measurement of cardiovascular endpoints. Our cardiovascular experts have experience with all modalities including the latest advancements in molecular imaging, allowing for an innovative solution for your trial endpoint requirements.

      Modality Endpoints
      Echocardiography (ECHO) Automated contour detection for analysis of segmental wall motion, left ventricular ejection fraction (LVEF), left ventricular mass, end-diastolic and end-systolic volumes
      Computed Tomography Angiography (CTA) Measurements of aorta, iliac, and carotid arteries including lumen diameter, percent diameter stenosis, lesion length, and calcium scoring
      Cardiac Magnetic Resonance Imaging (MRI) Measurements of global and regional left ventricular function including LVEF, left ventricular mass, wall motion, and wall thickening.  Measurements of myocardial perfusion, infarct size and viability.
      Magnetic Resonance Angiography (MRA) Analysis of arteriosclerosis and evaluation of MRA contrast agents
      Positron Emission Tomography (PET) Analysis of coronary artery disease Myocardial perfusion abnormalities Global and regional function of the ventricles
      Single Photon Emission Computed Tomography (SPECT) Analysis of coronary artery disease Myocardial perfusion abnormalities Global and regional function of the ventricle
      Multiple Gated Acquisition Scan (MUGA) Measurement of cardiac ejection fractions

      High Quality Imaging Data

      • Rigorous quality control processes to ensure high quality data

      • Qualification of imaging sites

      • Monitoring site adherence to regulatory guidelines

      • Specification of imaging requirements

      • Hardware/software assessments

      • Protocol training and technical support

      We track all patients enrolled in studies and all imaging data generated during the course of a clinical trial. Our expert technicians use innovative tools to deeply review, update, and assure compliance with clinical trial protocols and defined reading paradigms. This enables queries to be issued, tracked, and resolved. Our ICL collection management process is designed to detect early on any substandard image quality or violations of the imaging protocol.

      Our imaging core lab collection management process includes:

      • Collect image data
      • Query sites for missing data
      • Translate/digitize image data
      • Image QA/QC
      • Image data query resolution
      • Archive for long-term storage
      • And more

      Quantitative analysis backed by scientific expertise

      Quantitative Analysis

      Expert independent review of cardiovascular images and quantitative image analysis in support of novel therapeutics and medical devices. We apply state-of-the-art software to deliver reproducible, high quality data.

      Evaluation of Cardiac Structure and Function

      • Ejection fraction, cardiac volumes and mass
      • Heart valve assessment
      • Myocardial perfusion (viability, infarct size, scar tissue)
      • GL, LV, RV, and LA Strain
      • Coronary Artery Calcium (CAC) scoring

      With Bioclinica, you’ll receive powerful, comprehensive reporting services for sites and sponsors, which supports the management and review of data for clinical trials.

      Gain access to real-time reports, such as:

      • Metrics reports

      • Project status reports

      • Custom client reports

      • Analysis results reports

      • Safety and eligibility reports

      • Billing reports

      Bioclinica's transfer tools support a wide range of formats to meet client and project specifications — tools that enable clinical trial data delivery, including patient data and imaging data, to sponsors, external vendors, and partners.



      Medical Imaging Services for Clinical Trials

      Download Brochure



      Cardiovascular Imaging Expertise Sheet

      Download OVERVIEW SHEET

      Leader in Clinical Trial
      Management Solutions

      Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

      Bioclinica's #ClinicalDataManagement ecosystem of global experts, templates, coding tools and more fills the gap in…
      Bioclinica (Yesterday)
      With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a…
      Bioclinica (3 weeks ago)
      With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour…
      Bioclinica (3 weeks ago)
      Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff…
      Bioclinica (4 weeks ago)
      Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app…
      Bioclinica (4 weeks ago)
      Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin…
      Bioclinica (5 weeks ago)